1-4 of 4
Rashmi K. Murthy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular characterization and prospective evaluation of pathological response and outcomes with neoadjuvant therapy in metaplastic triple-negative breast cancer

Clinton Yam, Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qing-Qing Ding, Jason B. White, Elizabeth E. Ravenberg, Alyson R. Clayborn, Vicente Valero, Debu Tripathy, Senthilkumar Damodaran, Banu K. Arun, Jennifer K. Litton, Naoto T. Ueno, Rashmi K. Murthy, Bora Lim, Luis Baez, Xiaoxian Li, Aman U. Buzdar, Gabriel N. Hortobagyi, Alastair M. Thompson, Elizabeth A. Mittendorf, Gaiane M. Rauch, Rosalind P. Candelaria, Lei Huo, Stacy L. Moulder, Jeffrey T. Chang
Journal: Clinical Cancer Research
Clin Cancer Res clincanres.CCR-21-3100-A.2021.
DOI: https://doi.org/10.1158/1078-0432.CCR-21-3100
Published: 04 May 2022
View article
PDF
Includes: Supplementary data
Journal Articles

Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer

G. Travis Clifton, Diane Hale, Timothy J. Vreeland, Annelies T. Hickerson, Jennifer K. Litton, Gheath Alatrash, Rashmi K. Murthy, Na Qiao, Anne V. Philips, Jason J. Lukas, Jarrod P. Holmes, George E. Peoples, Elizabeth A. Mittendorf
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11): 2515–2523.
DOI: https://doi.org/10.1158/1078-0432.CCR-19-2741
Published: 01 June 2020
View article
PDF
Includes: Supplementary data
Journal Articles

Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

Funda Meric-Bernstam, Amber M. Johnson, Ecaterina E. Ileana Dumbrava, Kanwal Raghav, Kavitha Balaji, Michelle Bhatt, Rashmi K. Murthy, Jordi Rodon, Sarina A. Piha-Paul
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (7): 2033–2041.
DOI: https://doi.org/10.1158/1078-0432.CCR-18-2275
Published: 01 April 2019
View article
PDF
Includes: Supplementary data
Journal Articles

Phase I Study of ONT-380, a HER2 Inhibitor, in Patients with HER2+-Advanced Solid Tumors, with an Expansion Cohort in HER2+ Metastatic Breast Cancer (MBC)

Stacy L. Moulder, Virginia F. Borges, Tara Baetz, Tessa Mcspadden, Gina Fernetich, Rashmi K. Murthy, Renae Chavira, Kari Guthrie, Emma Barrett, Stephen K. Chia
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (14): 3529–3536.
DOI: https://doi.org/10.1158/1078-0432.CCR-16-1496
Published: 13 July 2017
View article
PDF